35Ãļt­ã»s½÷·ç·s«a¥é»sÃÄ
¥]¬A´_¬PÂåÃĵ¥5¤¤°êÃļt

[2022.03.19] µoªí
¡uÃÄ«~±M§Q¦À¡v«Å¥¬»P¥þ²y35®aÃļtñ¸p¨óij¡A¤¹³\¥¦­Ì¥Í²£¬ü°ê½÷·çÃļt·s«¬«aª¬¯f¬r¤fªAÃÄPaxlovidªº¥é»sÃÄ¡C¹Ï¬°½÷·ç©ó¼w°ê¥±µÜ³ùªº¼t©Ð¥¿¦b¥Í²£Paxlovid¡C¡]¸ô³zªÀ¡^

Áp¦X°ê¹õ«á¤ä«ùªº¤½¦@½Ã¥Í²Õ´¡uÃÄ«~±M§Q¦À¡v(Medicines Patent Pool¡A²ºÙMPP)©P¥|(17¤é)«Å¥¬¡A»P¥]¬A5®a¤¤°êÃļt¦b¤ºªº¥þ²y35®aÃļtñ¸p¨óij¡A¤¹³\¥¦­Ì¥Í²£¬ü°ê½÷·çÃļt(Pfizer)·s«¬«aª¬¯f¬r¤fªAÃÄPaxlovidªº¥é»sÃÄ(generic drugs)¡A¥H¨ÑÀ³95­Ó¤¤§C¦¬¤J°ê®aÀ³¹ï·s«a¬Ì±¡¡C

¨Ñ¤©95µo®i¤¤°ê®a

®Ú¾Ú¨óij¡A35®a¥ø·~¤¤¡A6®a±N­«ÂI¥Í²£Paxlovidªº¥D­n¦¨¤À¡A9®a±N­t³d¥Í²£»s¾¯¡A¨ä¾l20®a¦P®É¥Í²£Paxlovid¥D­n¦¨¤À©M»s¾¯¡CÀò±ÂÅv¥ø·~¹M§G12°ê¡A¥]¬A¥H¦â¦CTeva¡BÁ`³¡¦b¦L«×ªºSun¡BÁ`³¡¦b¬ü°êªºVatrisµ¥¡C¤¤°êªº5®aÃļt¬°´_¬PÂåÃÄ¡B¤W®ü­}ÁÉ¿Õ¡BµØ®üÃÄ·~¡B´¶¬¥ÃÄ·~©M¤E¬wÃÄ·~¡C¤E¬wÃÄ·~¶È¥Í²£¥D­n¦¨¤À¡A¨ä¥L¦P®É¥Í²£¥D­n¦¨¤À©M»s¾¯¡C

Paxlovid³Qµø¬°§Ü¬Ì­«­nªZ¾¹¡AÁ{þH´ú¸ÕÅã¥Ü¥i´î§C°ª¦M¯f¤H¤J°|²v¬ù90%¡C®Ú¾Ú­p¹º¡A35®aÃļt¥Í²£ªº¥é»sª©Paxlovid¡A±N¨ÑÀ³µo®i¤¤°ê®a¡A¨ü´f°ê¤¤¤£¥F¬Ì­]±µºØ²v§C©MÂåÅ@°ò«Ø¯Ü®zªº·s«a¬Ì±¡¡u°ª¦M°ê¡v¡C¦¹«e¡AMPP¤w»P27®aÃļtñ¸p¨óij¡A¥Í²£Àq¨FªF(Merck & Co's)·s«a¤fªAÃÄMolnupiravirªº¥é»sÃÄ¡A¨ÑÀ³105­Ó§C¦¬¤J©M¤¤µ¥¦¬¤J°ê®a¡CMolnupiravirªº´î§C¤J°|²v¸ûPaxlovid§C¡C

²ö¼w¯Ç¥Ó½Ð¬°¦¨¤H¥´²Ä¥|°w

ÁöµM·s«a¤fªAÃĤw­±¥@¡A¦ý³¡¤À°ê®aÄ~Äò¦Ò¼{§å­ã¦V¥Á²³¥´¡u²Ä¥|°w¡v¡C¬ü°êÃļt²ö¼w¯Ç(Moderna)¤w¦V­¹ª«¤ÎÃÄ«~ºÞ²z§½(FDA)¥Ó½Ð¬°¦¨¤H±µºØ²Ä¤G¾¯·s«a¬Ì­]¥[±j°w¡A»¡°Ñ¦Ò¤F¨ä¬Ì­]¦b¬ü°ê©M¥H¦â¦C¹ïOmicronÅܲ§®è«OÅ@¤Oªº¼Æ¾Ú«á´£¥X¥Ó½Ð¡C½÷·ç¤é«e¤w¦VFDA¥Ó½Ð¬°65·³©Î¥H¤W¤H¤h±µºØ²Ä¥|°w¡C

§¹¦¨±µºØªÌ¤J¹Ò¥[°ê¤ð¶·³±©ÊÃÒ©ú

ÀHþӬ̭]´¶¤Î©M¤fªAÃÄ­±¥@¡A³\¦h°ê®a³vº¥¶}©ñÃä¹Ò¡C¥[®³¤j¬F©²©P¥|«Å¥¬§¹¦¨±µºØ¬Ì­]ªº®È«È¡A±q4¤ë1¤é°_¤J¹Ò®É¤ð¶·´£¥æ¯f¬rÀË´ú³±©Ê³ø§i¡A¦ý¤´¥i¯à¦b¾÷³õ³Q­n¨D±µ¨üÀH¾÷®Ö»ÄÀË´ú¡A¦ýµ¥«Ýµ²ªG®É¤ð¶·¹jÂ÷¡C¥¼§¹¦¨±µºØ¬Ì­]ªº®È«È¡A¤´­n¥X¥Ü³±©Ê®Ö»ÄÀË´úÃÒ©ú¡A¶i¤J¥[®³¤j«áÁÙ­n¹jÂ÷ÀˬÌ14¤Ñ¡C

¥t¥~¡AÁú°ê©P¥|³æ¤é·s¼W40.7¸U©v½T¶E¡A¸û«e¤@¤Ñªº62¸U¤j´î¡C·í§½¬Q¤é«Å¥¬¡A¥»¤ë21¤é°_©ñ¼e¨p¤H»E·|¤H¼Æ­­¨î¡A¥Ñ²{®Éªº6¤H©ñ¼e¦Ü8¤H¡A¦ýÀ\ÆUµ¥Àç·~®É¶¡­­¨î¤´ºû«ù¦Ü±ß¤W11®É¬°¤î¡C

(¸ô³zªÀ/Politico/µØº¸µó¤é³ø/¥[®³¤jCTV/¤¤¥¡ªÀ)

§ó¦h°ê»Ú­n»D
NASA¤½¶}·s«¬µn¤ë¤õ½b
¬ü°ê¤ÓªÅÁ`¸p¡]NASA¡^©P¥|¡]17¤é¡^¦b¦òù¨½¹F¦{¥Ì°i­}¤ÓªÅ¤¤¤ß¤½¶}·s«¬µn¤ë¤õ½b¡u¤ÓªÅµo®g¨t²Î¡v¡]SLS¡^¤Î¡uÂy¤á®y¡v¡]Orion¡^¸ü¤H¤ÓªÅ... ¸Ô±¡
¿D¬w¬F©²Ävª§¤Î®ø¶OªÌ©e­û·|¡]ACCC¡^©P¤­¡]18¤é¡^¤J¸[Áp¨¹ªk°|¡A±±§iªÀ¥æºô¯¸facebook¡]fb¡^¥À¤½¥qMeta¡A«ü¸Ó¤½¥q¥¼¦³ªý¤î¶BÄFªÌ... ¸Ô±¡
Áp¦X°ê©P¤­¡]18¤é¡^µoªí¥»¦~«×¡m¥þ²y©¯ºÖ³ø§i¡n¡]World Happiness Report¡^¡AªâÄõ³sÄò²Ä5¦~°ª½õº]­º¡A¤¦³Á¡B¦B®q¡B·ç¤h©M²ü... ¸Ô±¡
¬ü°ê°ê®a¹B¿é¦w¥þ©e­û·|¡]NTSB¡^©P¥|¡]17¤é¡^ªí¥Ü¡A±o¦{¦w¼w¾|´µ¿¤¤@¦W13·³¨kµ£©P¤G±ß¾r¾p¤@½ø¹A¤Ò¨®¼²¦V¤@½ø«È³f¨®¡A³y¦¨9¤H¦º¤`¡A¥]¬A¨kµ£... ¸Ô±¡

©ú³øºô¯¸ ¡P ª©Åv©Ò¦³ ¡P ¤£±oÂà¸ü
Copyright © 2022 mingpaocanada.com All rights reserved.
Ming Pao Daily News A wholly owned subsidiary of Ming Pao Enterprise Corporation Ltd.
Toronto Chinese Newspaper

Chief Executive Officer: Ka Ming Lui | Executive Chief Editor: Richard Kwok Kai Ng
1355 Huntingwood Drive, Scarborough, Ontario, Canada M1S 3J1 | Tel.: (416) 321-0088 | Fax: (416) 321-5377 | Advertising Hotline Tel: (416) 673-8250